EGLN1 and cancer: Taken together, the data presented here show that YAP1 can be regulated by a novel nonclassical pathway under normoxic conditions, which involves PHD2 and VHL; absence of this regulation under hypoxic conditions stabilizes YAP1 protein and contributes to angiogenesis and cancer progression.